1. Volume 72, Issue 5, Pages 845-852 (November 2017)
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens 
Paul L. Nguyen, Zaid Haddad, Ashley E. Ross, Neil E. Martin, Samineh Deheshi, Lucia L.C. Lam, Jijumon Chelliserry, Jeffrey J. Tosoian, Tamara L. Lotan, Daniel E. Spratt, Radka S. Stoyanova, Sanoj Punnen, Kaye Ong, Christine Buerki, Maria Aranes, Tyler Kolisnik, Jennifer Margrave, Kasra Yousefi, Voleak Choeurng, Elai Davicioni, Bruce J. Trock, Christopher J. Kane, Alan Pollack, John W. Davis, Felix Y. Feng, Eric A. Klein 
European Urology 
Volume 72, Issue 5, Pages (November 2017)
DOI: /j.eururo
Copyright © 2017 European Association of Urology Terms and Conditions

2. Fig. 1
C-index for metastasis at 5-yr post-Bx. † C-index of the combined models was corrected for optimism.
CAPRA=Cancer of the Prostate Risk Assessment; NCCN=National Comprehensive Cancer Network.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions

3. Fig. 2
Cumulative incidence curves for Decipher, Cancer of the Prostate Risk Assessment (CAPRA), and National Comprehensive Cancer Network (NCCN) for metastasis endpoint. The dashed gray line represents the cohort average for metastasis risk.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions

4. Fig. 3
Cumulative incidence curves for Decipher, Cancer of the Prostate Risk Assessment (CAPRA), and National Comprehensive Cancer Network (NCCN) for prostate cancer-specific mortality (PCSM) endpoint. The dashed gray line represents the cohort average for PCSM risk.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions